Immunotherapy as a Downstaging Therapy for Liver Transplantation

Hepatology. 2020 Oct;72(4):1488-1490. doi: 10.1002/hep.31234.

Authors

Birgit Schwacha-Eipper^{1

2}, Iulia Minciuna¹, Vanessa Banz², Jean François Dufour^{1

2}

Affiliations

¹ Hepatology, Department of Biomedical Research, University of Bern, Bern, Switzerland.
² University Clinic for Visceral Surgery and Medicine, Inselspital, Bern, Switzerland.

PMID: 32171041
DOI: 10.1002/hep.31234

No abstract available

Publication types

Case Reports

MeSH terms

Carcinoma, Hepatocellular / therapy*
Humans
Immune Checkpoint Inhibitors / therapeutic use*
Immunotherapy
Liver Neoplasms / therapy*
Liver Transplantation*
Male
Middle Aged
Nivolumab / therapeutic use*

Substances

Immune Checkpoint Inhibitors
Nivolumab